Related Experiment Video
Updated: Sep 12, 2025

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
A CD4+ T lymphocyte-specific TCR/GSDMD/IL-2 axis facilitates antitumor immunity
Yihan Yao1, Lingling Wang1, Weiqin Jiang2
1Institute of Immunology and Bone Marrow Transplantation Center and.
Abstract:
Gasdermin (GSDM) family proteins mediate tumor pyroptosis and impact cancer progression, but other than that, their involvement in the tumor immune microenvironment remains largely unknown. Here, we show that activation of GSDMD in human tumor specimens mainly occurs in tumor-infiltrating leukocytes. Significantly, GSDMD deficiency or its inactivation in CD4+ T cells disabled CD8+ T cell-mediated antitumor immunity and caused tumor outgrowth in mice. Further study uncovered that, via inducing IL-2 production, GSDMD was required for CD4+ T cells to provide help to CD8+ T cell function. Mechanistically, GSDMD was cleaved by TCR stimulation-activated caspase-8 to form GSDMD-N pores, which enhanced Ca2+ influx for IL-2 induction. Moreover, GSDMD activation and function were conserved in human CD4+ T cells and associated with favorable prognosis and improved response to anti-PD-1 immunotherapy in colonic and pancreatic cancer. We believe this study identifies a new nonpyroptotic role of GSDMD in tumor immunity, proposing GSDMD as a potential target for cancer immunotherapy.
Insights
Gasdermin D (GSDMD) protein is crucial for CD4+ T cells to support CD8+ T cell antitumor immunity by inducing IL-2 production. This finding reveals a new role for GSDMD in cancer immunity.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Gasdermin (GSDM) proteins are known to mediate pyroptosis and influence cancer progression.
- The role of GSDM proteins in the tumor immune microenvironment is largely unexplored.
Purpose of the Study:
- To investigate the function of Gasdermin D (GSDMD) in the tumor immune microenvironment.
- To elucidate the non-pyroptotic roles of GSDMD in anti-tumor immunity.
Main Methods:
- Analysis of GSDMD activation in human tumor specimens.
- GSDMD deficiency and inactivation studies in CD4+ T cells using mouse models.
- Investigation of IL-2 production and T cell help mechanisms.
- Biochemical assays to study GSDMD pore formation and calcium influx.
Main Results:
- GSDMD activation in human tumors primarily occurs in tumor-infiltrating leukocytes.
- GSDMD deficiency in CD4+ T cells impairs CD8+ T cell-mediated anti-tumor immunity and promotes tumor growth.
- GSDMD is essential for CD4+ T cell-mediated help to CD8+ T cells via IL-2 induction.
- GSDMD-N pore formation enhances Ca2+ influx, leading to IL-2 production upon T cell receptor stimulation.
- GSDMD function is conserved in human CD4+ T cells and correlates with better prognosis and immunotherapy response.
Conclusions:
- GSDMD plays a critical non-pyroptotic role in orchestrating CD4+ T cell help for CD8+ T cell anti-tumor immunity.
- GSDMD activation is a potential biomarker for immunotherapy response.
- GSDMD represents a novel therapeutic target for enhancing cancer immunotherapy.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

